PharmaBoardroom

Interview: Daniel Pardo Bejarano – CEO, BOMI Mexico

Daniel Pardo Bejarano, CEO of BOMI Mexico, details the competitive advantages and the unique business approach that make BOMI the logistics partner of…

Interview: Matt Moran – Director, BioPharmaChem, Ireland

With nearly €4 billion of capital investment in large molecule manufacturing underway, Ireland’s strategy to become a premier destination for…

Italy Pharma Map

The following map shows the importance of the pharmaceutical industry to the highly regionalised Italian industry. Lombardy in the North of Italy…

Interview: Teodoro Padilla – Executive Director; Reiner…

Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and…

Sources of R&D Investment in Italy

The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

Interview: Ti Hwei How – President, SAPI, Singapore

The Singapore Association of Pharmaceutical Industries' (SAPI) recently appointed president, Ti Hwei How highlights several unique attributes that…

Interview: Dr. Benjamin Seet – Executive Director, A*STAR BMRC,…

The executive director of A*STAR’s Biomedical Research Council, Dr. Benjamin Seet highlights several remarkable milestones that the organization has…

French Dermo-Cosmetics: More than Skin Deep

France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

The Philippines: Healthcare Opportunity Knocks

The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant…